Vaccination with rEGVac elicits immunoprotection against different stages of Echinococcus granulosus life cycle: A pilot study
Vaccination with rEGVac elicits immunoprotection against different stages of Echinococcus granulosus life cycle: A pilot study
نویسندگان: محمد مصطفی پورسیف , بهروز نقیلی حکم آبادی , جابر دهقانی
کلمات کلیدی: Antigen, Echinococcus granulosus, Epitope, Freund's adjuvant, Immunoprotection, Vaccine
نشریه: 703 , 105883 , 218 , 2021
| نویسنده ثبت کننده مقاله |
محمد مصطفی پورسیف |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات ریز فناوری دارویی |
| کد مقاله |
75501 |
| عنوان فارسی مقاله |
Vaccination with rEGVac elicits immunoprotection against different stages of Echinococcus granulosus life cycle: A pilot study |
| عنوان لاتین مقاله |
Vaccination with rEGVac elicits immunoprotection against different stages of Echinococcus granulosus life cycle: A pilot study |
| ناشر |
7 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Vaccination against dog–sheep transmission cycle is necessary to control cystic echinococcosis (CE) infection. A multi-epitope multi-antigenic recombinant vaccine was developed–comprising the three putative vaccine antigens EG95, Eg14-3-3 and EgEnolase–was cloned and expressed. In a pilot experiment, the multi-antigen vaccine was assessed in 15 dogs and 15 sheep (five experimental groups and three animals in each group) by two subcutaneous doses 28 days apart. To evaluate the efficacy of the vaccine candidate first immunological analysis were done comprising IgG and IgE antibodies and the cytokine IL-4 in sera of the immunized dogs and sheep. Serum IgG, IgE, and IL-4, in particular in the dogs, were increased after the two rounds of vaccine candidate injection, while the total number of hydatid cysts was reduced (~85.43%). This pilot trial indicated significant immune protection efficacy against E. granulosus especially in dogs, while its efficacy in sheep was not as high as dogs. The multi-antigenic candidate vaccine is proposed as a protective vaccine modality in both dogs and sheep. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| rEGVac-Published-ActaTropica.pdf | 1400/01/12 | 22700996 | دانلود |